Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Spectral CT - a new supplementary method for preoperative assessment of pathological grades of esophageal squamous cell carcinoma

BMC Medical Imaging volume 23, Article number: 110 (2023) Cite this article

Abstract

Background

Spectral CT imaging parameters have been reported to be useful in the differentiation of pathological grades in different malignancies. This study aims to investigate the value of spectral CT in the quantitative assessment of esophageal squamous cell carcinoma (ESCC) with different degrees of differentiation.

Methods

There were 191 patients with proven ESCC who underwent enhanced spectral CT from June 2018 to March 2020 retrospectively enrolled. These patients were divided into three groups based on pathological results: well differentiated ESCC, moderately differentiated ESCC, and poorly differentiated ESCC. Virtual monoenergetic 40 keV-equivalent image (VMI40keV), iodine concentration (IC), water concentration (WC), effective atomic number (Eff-Z), and the slope of the spectral curve(λHU) of the arterial phase (AP) and venous phase (VP) were measured or calculated. The quantitative parameters of the three groups were compared by using one-way ANOVA and pairwise comparisons were performed with LSD. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic performance of these parameters in poorly differentiated groups and non-poorly differentiated groups.

Results

There were significant differences in VMI40keV, IC, Eff-Z, and λHU in AP and VP among the three groups (all p < 0.05) except for WC (p > 0.05). The VMI40keV, IC, Eff-Z, and λHU in the poorly differentiated group were significantly higher than those in the other groups both in AP and VP (all p < 0.05). In the ROC analysis, IC performed the best in the identification of the poorly differentiated group and non-poorly differentiated group in VP (AUC = 0.729, Sensitivity = 0.829, and Specificity = 0.569 under the threshold of 21.08 mg/ml).

Conclusions

Quantitative parameters of spectral CT could offer supplemental information for the preoperative differential diagnosis of ESCC with different degrees of differentiation.

Peer Review reports

Introduction

According to the global cancer statistics 2020, esophageal cancer ranks seventh in terms of incidence and sixth in mortality overall, the latter signifying that esophageal cancer is responsible for one in every 18 cancer deaths in 2020 [1]. The treatment strategies and prognosis evaluation for esophageal cancer are mainly determined by the clinical TNM stage and pathological TNM (pTNM) stage, the latter remains relevant for early-stage cancers and as an important staging and survival reference point [2]. The overall 5-year survival of patients with esophageal cancer ranges from 15 to 25%. Diagnoses made at earlier stages are associated with better outcomes than those made at later stages [3], the latter is more prone to lymph node metastasis and local recurrence as well as shorter survival [4]. In China, esophageal squamous cell carcinoma (ESCC) is the predominant pathological type of esophageal cancer [1]. A definitive diagnosis of esophageal lesions is based on histological examination; however, an invasive method is not always readily available, and local samples might not fully reflect the overall heterogeneity of the tumor. The degree of differentiation of esophageal cancer is an important component of pTNM staging of esophageal cancer, and well-differentiated esophageal cancer is less malignant and will be better treated compared to moderately and poorly differentiated esophageal cancer. Thus, an accurate and non-invasive method is urgently needed in evaluating the pathological grade of ESCC.

It is generally accepted that CT is an important modality for evaluating esophageal tumors. Conventional CT is often used to identify the location of primary lesions and distal metastases, but its role in determining pTNM is limited. Spectral CT has been widely used for qualitative and quantitative imaging of different malignancies and could provide more accurate and complete information on cancers for detection and prognoses evaluation. With the use of material decomposition techniques, one can obtain virtual monoenergetic images (VMI), iodine concentration (IC), water concentration (WC), effective atomic number (Eff-Z), or other material-specific information [5]. In recent years, spectral CT imaging parameters have been reported to be useful in the differentiation of pathological grades in different malignancies including glioma [6], pancreatic neuroendocrine neoplasms [7], gastric adenocarcinoma [8], ovarian tumours [9], non-small cell lung cancer [10], and clear cell renal cell carcinoma (ccRCC) [11]. However, to the best of our knowledge, spectral parameters have not been applied for the pathological grades of esophageal cancer so far.

Consequently, this study was conducted to explore the significance of quantitative assessment with several parameters derived from spectral CT in differentiating ESCC with different degrees of differentiation.

Materials and methods

Patient characteristics

This retrospective study was approved by the Ethics Committee of our hospital and all patients signed the informed consent. A total of 191 patients with histologically proven ESCC were enrolled in this study from June 2018 to March 2020. The inclusion criteria were as follows: (1) No contraindications to contrast-enhanced CT examination; (2) No radiation therapy or chemotherapy before surgery; (3) Within 1 week after spectral CT scan the lesions were resected; (4) Postoperative pathologic confirmation of ESCC. The main exclusion criteria were as follows: (1) Patients who were found to be allergic to iodine contrast agent before enhanced CT examination; (2) Patients who had already received radiation therapy or chemotherapy; (3) Images with poor quality due to artifacts.

Spectral CT image acquisition

All inspections were conducted using a Revolution CT scanner (GE Healthcare, Milwaukie USA) with the spectral CT acquisition mode. The scan protocol included a 5 mm slice thickness, tube voltage of 70 and 140 kV with a fast kilovolt peak–switching technique, CT automatic exposure control (AEC) systems adjusting the tube current, and gantry speed of 0.5 s per rotation, and helical pitch of 0.992:1. The nonionic contrast agent Iohexol (China, Jiangsu Yangtze River Pharmaceutical Group) was used for the enhanced examination of patients, containing 300mgI/ml of iodine, the weight-dependent dose of 1.5 ml/kg, and an infusion rate of 3.0 ml/s. Scanning was done when the CT value of the aortic arch reached 100 HU, and the arterial phase (AP) and venous phase (VP) started 30 and 60 s, respectively, after the administration of contrast agents.

Spectral CT image analysis

All spectral CT images were reconstructed with a slice thickness of 1.25 mm, and then the images were transferred to the workstation. Two radiologists with 6 and 20 years of experience in esophagus CT diagnosis measured and analyzed the imaging in a blinded and randomized manner respectively. A round or oval region of interest (ROI) was selected according to the size and location of the lesions to measure the virtual monoenergetic 40 keV-equivalent image (VMI40keV), IC, WC, and Eff-Z in both the AP and VP. To reduce measurement variation, ROIs were placed three times in the tumor area without distinguishable necrosis or hemorrhage, and the average of triplicate measurements was used as the final data value. The slope of the spectral curve (λHU) was defined as the difference between the CT value at 40 keV and that at 70 keV divided by the energy difference(30 keV), and it was calculated as follows: λHU = [(CT(40 keV)-CT(70 keV)]/(70 − 40) [12].

Pathological analysis

All tissues were obtained from surgical operation. Based on the 8th edition of AJCC classification [4], these patients were divided into three groups according to postoperative pathological results: well differentiated ESCC, moderately differentiated ESCC and poorly differentiated ESCC.

Statistical analysis

Statistical analyses were conducted using SPSS26.0. Quantitative variables are expressed as mean ± standard deviation, and categorical variables are presented as frequencies (percentages). The differences in VMI40keV, IC, WC, Eff-Z, and λHU of the three groups were statistically analyzed using one-way ANOVA and pairwise comparison was performed with LSD. Receiver operating characteristic (ROC) analysis was conducted for each parameter to differentiate the poorly differentiated and non-poorly differentiated groups.

Results

Patient characteristics

A total of 191 patients (mean age 68.49 ± 6.78 years), 157 men (mean age 68.34 ± 7.16 years), and 34 women (mean age 69.18 ± 4.64 years) were included. Characteristics of our patients are summarized in Table 1.

Table 1 Patient characteristics
Full size table

Quantitative spectral parameters comparison

There were significant differences in VMI40keV, IC, Eff-Z, and λHU in AP and VP among the three groups (all p < 0.05) except for WC (p > 0.05). The VMI40keV, IC, Eff-Z, and λHU in the poorly differentiated group were significantly higher than those in the other groups both in AP and VP (all p < 0.05; Table 2).

Table 2 Comparison of quantitative parameters among ESCC of different degrees of differentiation in AP and VP
Full size table

Quantitative diagnostic value evaluation

ROC curves for all spectral CT parameters are shown in Fig. 1. Table 3 shows AUCs, thresholds, Sensitivities, and Specificities based on the ROC analysis.

Fig. 1
figure 1

Receiver operating characteristic curves of each parameter for the differential diagnosis of the poorly differentiated group (82 cases) from the non-poorly differentiated group (109 cases) in the arterial phase and venous phase, respectively. a the arterial phase; b the venous phase. VMI, virtual monoenergetic image; IC, iodine concentration; WC, water concentration; Eff-Z, effective atomic number; λHU, the slope of the spectral curve

Full size image
Table 3 AUCs, thresholds, sensitivities, and specificities for distinguishing the poorly differentiated group from the non-poorly differentiated group in AP and VP
Full size table

In the identification of poorly differentiated groups and non-poorly differentiated groups. VMI40keV, IC, Eff-Z, and λHU in VP showed an area under the ROC curve (AUC) of 0.725, 0.729, 0.729, and 0.723, respectively, while AP showed an AUC of 0.612, 0.616, 0.619, and 0.617, respectively. The highest sensitivity, specificity, and AUC were observed for IC in VP, the sensitivity of it in the identification between the poorly differentiated group and the non-poorly differentiated group was 82.9%, while the specificity was 56.9% under the threshold of 21.08 mg/ml.

Discussion

The pathological differentiation grade of ESCC influences the prognosis, as tumor grade increases, it is more likely to have a poorer prognosis and an elevated risk of death [10]. Our results showed that quantitative parameters derived from spectral CT, including VMI40keV, IC, Eff-Z, and λHU both in AP and VP, could be used to distinguish pathological grades of ESCC, as shown in Figs. 2, 3 and 4.

Fig. 2
figure 2

Spectral images in venous phase and Photomicrograph (original magnification, ×100) example of well differentiated ESCC (male, 71 years old). a VMI40 keV=185.88 HU, b IC = 18.88 mg/ml, c λHU = 3.57, d WC = 1029.58 mg/ml, e Eff-Z = 8.71, f Photomicrograph (original magnification, ×100). VMI, virtual monoenergetic image; IC, iodine concentration; WC, water concentration; λHU, the slope of the spectral curve; Eff-Z, effective atomic number

Full size image
Fig. 3
figure 3

Spectral images in venous phase and Photomicrograph (original magnification, ×100) example of moderately differentiated ESCC (male, 68 years old). a VMI40 keV=225.76 HU, b IC = 23.10 mg/ml, c λHU = 4.36, d WC = 1034.81 mg/ml, e Eff-Z = 8.93, f photomicrograph (original magnification, ×100). VMI, virtual monoenergetic image; IC, iodine concentration; WC, water concentration; λHU, the slope of the spectral curve; Eff-Z, effective atomic number

Full size image
Fig. 4
figure 4

Spectral images in venous phase and Photomicrograph (original magnification, ×100) example of poorly moderately differentiated ESCC (female, 64 years old). a VMI40 keV=261.35 HU, b IC = 28.52 mg/ml, c λHU = 5.36, d: WC = 1026.40 mg/ml, e Eff-Z = 9.20, f Photomicrograph (original magnification, ×100). VMI, virtual monoenergetic image; IC, iodine concentration; WC, water concentration; λHU, the slope of the spectral curve; Eff-Z, effective atomic number

Full size image

Spectral CT greatly reduces beam-hardening artifacts and generates VMIs with more accurate CT attenuation numbers at every energy level [13]. VMI40keV reconstructions provided higher image quality due to a higher lesion to background attenuation ratio, i.e., higher contrast [14, 15]; Thus, we selected the 40 keV image for this study. In the present study, VMI40keV in the AP and VP was significantly different among the three groups, which concurs with a previous study [13].

The distribution of iodine in the tissue is strongly correlated with local blood volume and vascular density [16]. Several studies have shown that IC correlates well with higher blood flow and vascularization [14, 17,18,19,20,21,22]. In our study, IC in the AP and VP was significantly different among the three groups, as tumor grade increased, it also increased. To be more precise, IC in the well differentiated group was the lowest while in the poorly differentiated ESCC group was the highest, signifying that the iodine uptake and vascularity of the low-grade ESCCs are lower than that of high-grade ESCCs.

Additionally, Eff-Z, another quantitative index for different materials which represents the composite atom for a compound or mixture of various materials and is important to predict how x-rays interact with a substance [7], was analyzed in the current study. Previous studies have indicated that Eff-Z could depict lesion characterization and could be used to differentiate tumors [16, 23,24,25]. In our study, the same conclusions were reached. There were significant differences in Eff-Z among the three groups in both AP and VP. Eff-Z in high-grade ESCCs was higher than in low-grade ESCCs, indicative of the feasibility of Eff-Z as a differentiating factor for ESCCs with different degrees of differentiation.

Regarding the λHU of ESCC, λHU and the tumor pathological grade showed a significant association during both phases, and tumors with a lower grade had lower λHU. The spectral curve reflects different lesions or tissues that absorb X-rays at different rates [26]. Thus, our study indicated that with the increase in pathological grade of ESCC, the local enhancement and the iodine contrast agent of local lesions increased, which concurred with previous studies [9,10,11].

With regards to WC, it is not dependent on photon energy and is less affected by the beam hardening effect, unlike the CT attenuation number, and therefore it is a more reliable parameter in tumor characterization [27]. However, inconsistent with previous studies [9, 28], our study demonstrated that WC was not significantly different among the three groups, which was useless for differentiating pathological grades of ESCC. This may be related to the small sample size of this study, which needs further study and verification in the future.

The prognosis of low-grade ESCC is better than high-grade ESCC, it will be of great value if we can distinguish them from each other on spectral CT. Thus, in our study ROC was generated to evaluate the diagnostic performance of spectral parameters to distinguish between the poorly differentiated group and the non-poorly differentiated group. The best diagnostic performance was found for IC in VP using a threshold value of 21.08 mg/ml, which resulted in a sensitivity, specificity, and AUC of 0.829, 0.569, and 0.729, respectively, also suggesting that tumor cells were metabolized vigorously and blood supply was abundant [28]. The diagnostic efficiency of spectral parameters was lower in the AP than in the VP, which is consistent with a previous study [12]. This may be because the contrast medium can fill the microvessels and penetrates the basement membrane into the intercellular space in the VP [24]. Therefore, the spectral parameters of the VP can better reflect the histological characteristics of the tumor.

This study still has some limitations. Firstly, the study included a relatively small number of ESCC patients. Secondly, there is an inherent selection bias due to this study’s retrospective nature. Thirdly, our study was based on the patients with ESCC, therefore, it can’t be applied to other esophageal tumors, such as esophageal adenocarcinoma (EAC). Moreover, our study primarily focused on esophageal lesions without lymph node involvement. However, we encourage subsequent studies addressing these problems.

Conclusions

In conclusion, parameters derived from spectral CT imaging could offer supplemental information to differentiate ESCC with different degrees of differentiation, which is particularly important in patients who can’t receive biopsy or surgery and might be a useful technology to help guide appropriate clinical diagnosis and prognosis.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article and its additional files.

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

    Article  PubMed  Google Scholar 

  2. Rice TW, Ishwaran H, Ferguson MK, Blackstone EH, Goldstraw P. Cancer of the Esophagus and Esophagogastric Junction: an Eighth Edition staging primer. J Thorac Oncol. 2017;12(1):36–42.

    Article  PubMed  Google Scholar 

  3. Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. The Lancet. 2013;381(9864):400–12.

    Article  Google Scholar 

  4. Jiang D, Wang H, Song Q, Wang H, Wang Q, Tan L, Hou Y. Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification. J Cancer. 2020;11(7):1808–15.

    Article  PubMed  PubMed Central  Google Scholar 

  5. McCollough CH, Leng S, Yu L, Fletcher JG. Dual- and multi-energy CT: principles, Technical Approaches, and clinical applications. Radiology. 2015;276(3):637–53.

    Article  PubMed  Google Scholar 

  6. Yingying L, Zhe Z, Xiaochen W, Xiaomei L, Nan J, Shengjun S. Dual-layer detector spectral CT-a new supplementary method for preoperative evaluation of glioma. Eur J Radiol. 2021;138:109649.

    Article  PubMed  Google Scholar 

  7. Li WX, Miao F, Xu XQ, Zhang J, Wu ZY, Chen KM, Yan FH, Lin XZ. Pancreatic neuroendocrine neoplasms: CT spectral imaging in Grading. Acad Radiol. 2021;28(2):208–16.

    Article  PubMed  Google Scholar 

  8. Lu Z, Wu S, Yan C, Chen J, Li Y. Clinical value of energy spectrum curves of dual-energy computer tomography may help to predict pathological grading of gastric adenocarcinoma. Transl Cancer Res. 2021;10(1):1–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Elsherif SB, Zheng S, Ganeshan D, Iyer R, Wei W, Bhosale PR. Does dual-energy CT differentiate benign and malignant ovarian tumours? Clin Radiol. 2020;75(8):606–14.

    Article  CAS  PubMed  Google Scholar 

  10. Lin LY, Zhang Y, Suo ST, Zhang F, Cheng JJ, Wu HW. Correlation between dual-energy spectral CT imaging parameters and pathological grades of non-small cell lung cancer. Clin Radiol. 2018;73(4):412. e411-412 e417.

    Article  Google Scholar 

  11. Wei J, Zhao J, Zhang X, Wang D, Zhang W, Wang Z, Zhou J. Analysis of dual energy spectral CT and pathological grading of clear cell renal cell carcinoma (ccRCC). PLoS ONE. 2018;13(5):e0195699.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Deng L, Zhang G, Lin X, Han T, Zhang B, Jing M, Zhou J. Comparison of spectral and perfusion computed Tomography Imaging in the Differential diagnosis of Peripheral Lung Cancer and Focal Organizing Pneumonia. Front Oncol. 2021;11:690254.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Han D, Yu Y, He T, Yu N, Dang S, Wu H, Ren J, Duan X. Effect of radiomics from different virtual monochromatic images in dual-energy spectral CT on the WHO/ISUP classification of clear cell renal cell carcinoma. Clin Radiol. 2021;76(8):627. e623-627 e629.

    Article  Google Scholar 

  14. Lohofer FK, Kaissis GA, Koster FL, Ziegelmayer S, Einspieler I, Gerngross C, Rasper M, Noel PB, Koerdt S, Fichter A, et al. Improved detection rates and treatment planning of head and neck cancer using dual-layer spectral CT. Eur Radiol. 2018;28(12):4925–31.

    Article  PubMed  Google Scholar 

  15. Nagayama Y, Tanoue S, Inoue T, Oda S, Nakaura T, Utsunomiya D, Yamashita Y. Dual-layer spectral CT improves image quality of multiphasic pancreas CT in patients with pancreatic ductal adenocarcinoma. Eur Radiol. 2020;30(1):394–403.

    Article  PubMed  Google Scholar 

  16. Wang X, Liu D, Zeng X, Jiang S, Li L, Yu T, Zhang J. Dual-energy CT quantitative parameters for evaluating immunohistochemical biomarkers of invasive breast cancer. Cancer Imaging. 2021;21(1):4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Boning G, Adelt S, Feldhaus F, Fehrenbach U, Kahn J, Hamm B, Streitparth F. Spectral CT in clinical routine imaging of neuroendocrine neoplasms. Clin Radiol. 2021;76(5):348–57.

    Article  CAS  PubMed  Google Scholar 

  18. Adam SZ, Rabinowich A, Kessner R, Blachar A. Spectral CT of the abdomen: where are we now? Insights Imaging. 2021;12(1):138.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Lennartz S, Tager P, Zopfs D, Iuga AI, Reimer RP, Zaske C, Grosse Hokamp N, Maintz D, Heidenreich A, Drzezga A, et al. Lymph Node Assessment in prostate Cancer: evaluation of iodine quantification with spectral detector CT in correlation to PSMA PET/CT. Clin Nucl Med. 2021;46(4):303–9.

    Article  PubMed  Google Scholar 

  20. Sun X, Niwa T, Ozawa S, Endo J, Hashimoto J. Detecting lymph node metastasis of esophageal cancer on dual-energy computed tomography. Acta Radiol. 2022;63(1):3–10.

    Article  PubMed  Google Scholar 

  21. Ge X, Yu J, Wang Z, Xu Y, Pan C, Jiang L, Yang Y, Yuan K, Liu W. Comparative study of dual energy CT iodine imaging and standardized concentrations before and after chemoradiotherapy for esophageal cancer. BMC Cancer. 2018;18(1):1120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Yang CB, Zhang S, Jia YJ, Yu Y, Duan HF, Zhang XR, Ma GM, Ren C, Yu N. Dual energy spectral CT imaging for the evaluation of small hepatocellular carcinoma microvascular invasion. Eur J Radiol. 2017;95:222–7.

    Article  PubMed  Google Scholar 

  23. Buus TW, Sandahl M, Thorup KS, Rasmussen F, Redsted S, Christiansen P, Jensen AB, Pedersen EM. Breast cancer: comparison of quantitative dual-layer spectral CT and axillary ultrasonography for preoperative diagnosis of metastatic axillary lymph nodes. Eur Radiol Exp. 2021;5(1):16.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Zhang Z, Zou H, Yuan A, Jiang F, Zhao B, Liu Y, Chen J, Zuo M, Gong L. A single enhanced dual-energy CT scan may distinguish lung squamous cell Carcinoma from Adenocarcinoma during the venous phase. Acad Radiol. 2020;27(5):624–9.

    Article  CAS  PubMed  Google Scholar 

  25. Zhou Y, Hou P, Zha K, Liu D, Wang F, Zhou K, Gao J. Spectral computed tomography for the quantitative Assessment of Patients with Carcinoma of the Gastroesophageal Junction: initial differentiation between a diagnosis of squamous cell carcinoma and adenocarcinoma. J Comput Assist Tomogr. 2019;43(2):187–93.

    Article  PubMed  Google Scholar 

  26. Brooks RA. A quantitative theory of the Hounsfield unit and its application to dual energy scanning. J Comput Assist Tomogr. 1977;1(4):487–93.

    Article  CAS  PubMed  Google Scholar 

  27. Liu G, Li M, Li G, Li Z, Liu A, Pu R, Cao H, Liu Y. Assessing the blood supply status of the Focal Ground-Glass opacity in lungs using Spectral Computed Tomography. Korean J Radiol. 2018;19(1):130–8.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Zhang B, Wu Q, Qiu X, Ding X, Wang J, Li J, Sun P, Hu X. Effect of spectral CT on tumor microvascular angiogenesis in renal cell carcinoma. BMC Cancer. 2021;21(1):874.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Dr. Jiayang Song for the statistical advice of this study.

Funding

This study was supported by Jiangsu Province’s 333 High-Level Talent Project (grant number: BRA2020193), Jiangsu Provincial Medical Youth Talent (grant number: QNRC2016509), and Jiangsu Provincial High-Level Talent Project (grant number: LGY2018032). The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Author information

Authors and Affiliations

  1. Department of Radiology, Taizhou People’s Hospital, NO.366 Taihu Road, Yiyaogaoxin District, Taizhou, 225300, Jiangsu, China

    Yi Wang, Weizhong Tian, Shuangfeng Tian, Liang He, Jianguo Xia & Ji Zhang

Authors
  1. Yi Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Weizhong Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuangfeng Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Liang He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jianguo Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ji Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YW contributed to the conception and design of the study, data analysis, and writing of the manuscript. JZ and JX contributed to performing the experiments and writing and revising the manuscript. WT contributed to the interpretation of the data. ST and LH contributed to the data collection. All authors accept responsibility for the integrity of the data and the accuracy of the data analysis. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Jianguo Xia or Ji Zhang.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Ethical Committee of the Taizhou People's Hospital and the requirement for informed consent was waived by the Ethical Committee. The study was performed in accordance with the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Y., Tian, W., Tian, S. et al. Spectral CT - a new supplementary method for preoperative assessment of pathological grades of esophageal squamous cell carcinoma. BMC Med Imaging 23, 110 (2023). https://doi.org/10.1186/s12880-023-01068-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12880-023-01068-5

Keywords

BMC Medical Imaging

ISSN: 1471-2342

Contact us